BRKR Bruker Corp

Price (delayed)

$79.04

Market cap

$11.99B

P/E Ratio

44.4

Dividend/share

$0.16

EPS

$1.78

Enterprise value

$12.24B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions ...

Highlights
BRKR's EPS has surged by 75% year-on-year and by 15% since the previous quarter
The net income has surged by 72% year-on-year and by 14% since the previous quarter
The quick ratio has decreased by 19% YoY but it has increased by 3.7% from the previous quarter
BRKR's price to earnings (P/E) is 10% higher than its 5-year quarterly average of 40.5 but 8% lower than its last 4 quarters average of 48.4

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
151.66M
Market cap
$11.99B
Enterprise value
$12.24B
Valuations
Price to earnings (P/E)
44.4
Price to book (P/B)
11.1
Price to sales (P/S)
5.07
EV/EBIT
32.71
EV/EBITDA
26.5
EV/Sales
5.18
Earnings
Revenue
$2.36B
EBIT
$374.2M
EBITDA
$462M
Free cash flow
$258.5M
Per share
EPS
$1.78
Free cash flow per share
$1.71
Book value per share
$7.12
Revenue per share
$15.6
TBVPS
$17.08
Balance sheet
Total assets
$3.13B
Total liabilities
$2.04B
Debt
$827M
Equity
$1.08B
Working capital
$1.07B
Liquidity
Debt to equity
0.77
Current ratio
2.16
Quick ratio
1.13
Net debt/EBITDA
0.55
Margins
EBITDA margin
19.6%
Gross margin
50%
Net margin
11.4%
Operating margin
17%
Efficiency
Return on assets
8.8%
Return on equity
27%
Return on invested capital
20.5%
Return on capital employed
17%
Return on sales
15.8%
Dividend
Dividend yield
0.2%
DPS
$0.16
Payout ratio
9%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
-2.8%
1 week
-5.02%
1 month
-2.32%
1 year
51.1%
YTD
46.02%
QTD
1.2%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$2.36B
Gross profit
$1.18B
Operating income
$400.7M
Net income
$270.3M
Gross margin
50%
Net margin
11.4%
The net income has surged by 72% year-on-year and by 14% since the previous quarter
BRKR's operating income has surged by 58% year-on-year and by 9% since the previous quarter
Bruker's net margin has increased by 43% YoY and by 9% from the previous quarter
BRKR's operating margin is up by 32% YoY and by 4.3% QoQ

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
P/E
44.4
P/B
11.1
P/S
5.07
EV/EBIT
32.71
EV/EBITDA
26.5
EV/Sales
5.18
BRKR's EPS has surged by 75% year-on-year and by 15% since the previous quarter
BRKR's price to earnings (P/E) is 10% higher than its 5-year quarterly average of 40.5 but 8% lower than its last 4 quarters average of 48.4
The stock's price to book (P/B) is 52% more than its 5-year quarterly average of 7.3 and 8% more than its last 4 quarters average of 10.3
BRKR's equity is up by 13% YoY and by 7% QoQ
The stock's price to sales (P/S) is 54% more than its 5-year quarterly average of 3.3 and 8% more than its last 4 quarters average of 4.7
Bruker's revenue has increased by 21% YoY and by 4.3% QoQ

Efficiency

How efficient is Bruker business performance
Bruker's return on invested capital has surged by 65% YoY and by 9% QoQ
BRKR's return on assets has surged by 60% year-on-year and by 11% since the previous quarter
Bruker's return on equity has surged by 57% YoY and by 10% QoQ
BRKR's return on sales is up by 35% year-on-year and by 5% since the previous quarter

Dividends

What is BRKR's dividend history
DPS
$0.16
Dividend yield
0.2%
Payout ratio
9%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 53% greater than its total liabilities
BRKR's current ratio is down by 19% year-on-year but it is up by 4.9% since the previous quarter
The quick ratio has decreased by 19% YoY but it has increased by 3.7% from the previous quarter
Bruker's debt is 23% less than its equity
BRKR's debt to equity is down by 16% year-on-year and by 7% since the previous quarter
BRKR's equity is up by 13% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.